AUTL

NASD Autolus Therapeutics Plc Sponsored ADR
Oct 16, 2026 · 8:34 AM ET LAST TRADE Market Closed

$1.72 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.72

YTD change
-13.57%
vs 20-day SMA
-6.25%
vs 200-day SMA
+2.54%

Price ranges

Previous day
$1.68 $1.74
open $1.70 close $1.72
+$0.02 (+1.18%)
Today
$0.00 $0.00
$1.72
Past week
$1.60 $1.82
from $1.77 now $1.72
-$0.05 (-2.82%)
Past month
$1.60 $2.08
from $1.92 now $1.72
-$0.20 (-10.42%)
This year
$1.18 $2.58
from $1.99 now $1.72
-$0.27 (-13.57%)

Price & Performance

+0.11 (+6.83%) / 6M

$1.31$1.75$2.19$2.63Apr 16Jul 17Oct 15

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 96.8% away from all-time highs of $53.24
  • AUTL is down 14% since the beginning of the year
  • AUTL is up 2% over the past 12 months
  • AUTL is down 10% over the past 1 month
  • 5% of all AUTL investors are betting against AUTL

AUTL reads neutral: price sits above one of the two key moving averages, the 12-month move is +2.4%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.15
Earnings momentum +7.6% Quarterly EPS growth
Quarterly change +7.6%

Valuation

P/E ratio N/A
Enterprise value $622.5M
Beta 3.30

Balance sheet & scale

IncomeN/A
Revenue$117.3M
Cash$203.1M
Debt$367.8K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $457.8M

Autolus Therapeutics Plc is a biopharmaceutical company, which engages in the development and commercialization of gene therapies. It uses proprietary and modular T cell programming technologies that are designed to recognize cancer cells, break down their defense mechanisms, and attack and kill these cells. The company was founded by Martin Pule in September 2014 and is headquartered in London, the United Kingdom.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $434.03 +1.86%
MRNA Moderna, Inc. $236.50 +4.51%
RVMD Revolution Medicines, Inc. $189.26 -2.20%
ROIV Roivant Sciences Ltd. $34.04 +1.25%
BNTX BioNTech SE Sponsored ADR $90.20 +1.74%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.